SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001047469-15-003392
Filing Date
2015-04-10
Accepted
2015-04-10 17:05:47
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-4/A a2224155zs-4a.htm S-4/A 1927853
2 EX-23.1 a2224155zex-23_1.htm EX-23.1 3381
3 EX-23.2 a2224155zex-23_2.htm EX-23.2 3953
4 EX-23.3 a2224155zex-23_3.htm EX-23.3 3136
5 EX-99.1 a2224155zex-99_1.htm EX-99.1 5529
6 EX-99.2 a2224155zex-99_2.htm EX-99.2 3988
8 G1020868.JPG g1020868.jpg GRAPHIC 5753
9 G445933.JPG g445933.jpg GRAPHIC 7906
10 G409601.JPG g409601.jpg GRAPHIC 7849
11 filename11.htm CORRESP 35148
  Complete submission text file 0001047469-15-003392.txt   2014052
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-202921 | Film No.: 15765047
SIC: 2834 Pharmaceutical Preparations